Literature DB >> 34084236

Posttransplant Diabetes Mellitus Incidence and Risk Factors in Adult Liver Transplantation Recipients.

N Gulsoy Kirnap1, M Kirnap2, O Alshalabi2, N B Tutuncu1, M Haberal2.   

Abstract

AIM: Posttransplant diabetes mellitus (PTDM) is a metabolic complication that usually occurs after liver transplantation (LT) due to immunosuppression. In this study, our aim was to identify PTDM incidence after LT in our center and the potential risk factors.
MATERIALS AND METHODS: In this study, 238 adult LT patients were evaluated in terms of PTDM development.
RESULTS: Of 238 patients included in the study, 170 (71.4%) were male, 68 (28.6%) were female and the mean age was 43.5± 13.7 years. Of all patients, PTDM developed in 24 (10.1%). Transient-Hyperglycemia (t-HG) was detected in 31 (13%) patients. PTDM and t-HG patients had a greater body weight than non-PTDM patients (BMI kg/m2: 27.6± 5.3, 25.8± 4.3and 23.9± 3.3, respectively p<0.001 p= 0.028). PTDM and t-HG patients mean age was higher than non-PTDM patients (51.5± 9.68, 48.2± 11.1 and 41.5± 14 years, respectively, p= 0.002 p= 0.023). In the univariate analysis, the only independent risk factor for PTDM was age (OR 1.93, 95% CI 1.31-2.97).
CONCLUSION: Age is the most important risk factor for PTDM development after LT. PTDM was found more common in the patient group with greater body weight. Patients with older age and greater body weight should be examined more carefully for PTDM before LT. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  posttransplant complication; posttransplant hyperglycemia; transient hyperglycemia

Year:  2020        PMID: 34084236      PMCID: PMC8126401          DOI: 10.4183/aeb.2020.449

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  37 in total

1.  New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry.

Authors:  Qi Ling; Xiao Xu; Haiyang Xie; Kai Wang; Penghui Xiang; Runzhou Zhuang; Tian Shen; Jian Wu; Weilin Wang; Shusen Zheng
Journal:  Liver Int       Date:  2016-01-20       Impact factor: 5.828

Review 2.  Posttransplant diabetes mellitus--a review.

Authors:  R M Jindal
Journal:  Transplantation       Date:  1994-12-27       Impact factor: 4.939

3.  Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.

Authors:  J Hjelmesaeth; A Hartmann; J Kofstad; J Stenstrøm; T Leivestad; T Egeland; P Fauchald
Journal:  Transplantation       Date:  1997-10-15       Impact factor: 4.939

4.  Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.

Authors:  F Vincenti; S Friman; E Scheuermann; L Rostaing; T Jenssen; J M Campistol; K Uchida; M D Pescovitz; P Marchetti; M Tuncer; F Citterio; A Wiecek; S Chadban; M El-Shahawy; K Budde; N Goto
Journal:  Am J Transplant       Date:  2007-03-12       Impact factor: 8.086

Review 5.  Guidelines for the treatment and management of new-onset diabetes after transplantation.

Authors:  Alan Wilkinson; Jaime Davidson; Francesco Dotta; Philip D Home; Paul Keown; Bryce Kiberd; Alan Jardine; Naomi Levitt; Piero Marchetti; Mariana Markell; Sarala Naicker; Philip O'Connell; Mark Schnitzler; Eberhard Standl; Jose-Vicente Torregosa; Kazuharu Uchida; Hannah Valantine; Federico Villamil; Flavio Vincenti; Martin Wissing
Journal:  Clin Transplant       Date:  2005-06       Impact factor: 2.863

6.  Expanded Criteria for Hepatocellular Carcinoma in Liver Transplant.

Authors:  Mehmet Haberal; Aydıncan Akdur; Gökhan Moray; Gülnaz Arslan; Figen Özçay; Haldun Selçuk; Handan Özdemir
Journal:  Exp Clin Transplant       Date:  2017-03       Impact factor: 0.945

7.  New-onset diabetes after liver transplantation and its impact on complications and patient survival.

Authors:  Chaoyang Lv; Yao Zhang; Xianying Chen; Xiaowu Huang; Mengjuan Xue; Qiman Sun; Ting Wang; Jing Liang; Shunmei He; Jian Gao; Jian Zhou; Mingxiang Yu; Jia Fan; Xin Gao
Journal:  J Diabetes       Date:  2015-03-24       Impact factor: 4.006

8.  Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus.

Authors:  Kevin C Abbott; Krista L Lentine; Jay R Bucci; Lawrence Y Agodoa; Jonathan M Koff; Kent C Holtzmuller; Mark A Schnitzler
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

9.  A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.

Authors:  E Steve Woodle; M Roy First; John Pirsch; Fuad Shihab; A Osama Gaber; Paul Van Veldhuisen
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

Review 10.  New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management.

Authors:  Mariana Markell
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.